F573 for injection Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

Beijing Continent Pharmaceutical Co, Ltd.1

Indications

Acute Liver Failure1
Acute on Chronic Liver Failure1
Liver Disease1

Other1 trial

F573 for Injection for the Treatment of Liver Injury/Failure

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.